ABSTRACT
The aim of this chapter is to provide the reader with an appreciation of the principles and requirements for registering and marketing injectable drug products as dispersed systems. These dosage forms offer unique characteristics having certain distinct advantages over more conventional solid and liquid sterile products. Such unique characteristics also present special challenges in the manufacturing and control of these dosage forms.
